{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Psychedelic News Feed","title":"Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/3b62bac6\"></iframe>","width":"100%","height":180,"duration":1399,"description":"In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through the last two weeks in the psychedelics field, including these stories:\nUsona Institute files its psilocybin for major depressive disorder new drug application with FDA\nFDA approves NRx Pharmaceuticals’ preservative-free generic ketamine\nWe share our analysis of 610 public comments on FDA’s psychedelics docket\nICER is set to review Compass Pathways’ psilocybin for treatment-resistant depression\nMore takeaways from The Psychedelic Healthcare Forum\nOther stories\n\nRead more:\nUsona Files Psilocybin for Depression NDA as Race With Compass Tightens\nMostly Supportive, Somewhat Divided: Stakeholders Respond to FDA’s Psychedelics Docket \nFDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending\nPharma Moves In: Investors, Developers and Lilly’s Carole Ho at the Psychedelic Healthcare Forum\nTake part in Johns Hopkins’ psychedelic research survey \n\nThe Psychedelic News Feed is published by Psychedelic Alpha and airs every two weeks.\n\nThis episode of The Psychedelic News Feed is supported by UBC. As psychedelic therapies move toward potential approvals, UBC helps sponsors navigate the evidence generation, pharmacovigilance, and comprehensive risk management strategies that support a path forward grounded in patient safety. Learn more at ubc.com.\n\nSend us your questions and comments at pod@psychedelicalpha.com \n\nRead more and join our newsletter at https://psychedelicalpha.com\n\nFollow us on Instagram @psychedelicalpha, X @Psyched_Alpha, and LinkedIn.\n\nSubscribe to Pα+ for premium insights: https://psychedelicalpha.com/join/","thumbnail_url":"https://img.transistorcdn.com/JloIlpLTBLPjk3I75jU_cRq8srB2BvAcUvjRPrSEM2M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83MDc4/NWQ1YzQ4ODk0YjVm/NzE0OWNlOTkyOWI5/MTU3OC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}